{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:03:25Z","timestamp":1756771405469,"version":"3.44.0"},"reference-count":31,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016063","name":"Stichting Steunfonds Uitzicht","doi-asserted-by":"publisher","award":["2019-18"],"award-info":[{"award-number":["2019-18"]}],"id":[{"id":"10.13039\/100016063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010302","name":"Algemene Nederlandse Vereniging ter voorkoming van Blindheid","doi-asserted-by":"publisher","award":["Via Uitzicht 2019-18"],"award-info":[{"award-number":["Via Uitzicht 2019-18"]}],"id":[{"id":"10.13039\/501100010302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010318","name":"Landelijke Stichting voor Blinden en Slechtzienden","doi-asserted-by":"publisher","award":["Via Uitzicht 2019-18"],"award-info":[{"award-number":["Via Uitzicht 2019-18"]}],"id":[{"id":"10.13039\/501100010318","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Erasmus MC fellowship to V.J.M. Verhoeven","award":["Year 2021"],"award-info":[{"award-number":["Year 2021"]}]},{"name":"Prof. dr. Henkes stichting","award":["without grand number"],"award-info":[{"award-number":["without grand number"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2024,7,25]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>This study aimed to evaluate the effectiveness of somatostatin analogues (SA) for cystoid maculopathy (CM) in retinitis pigmentosa (RP) patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and methods<\/jats:title>\n                  <jats:p>In this retrospective case series, clinical and imaging characteristics of 28 RP patients with CM, unresponsive to carbonic anhydrase inhibitors, were collected from medical charts. All patients received SA treatment as an alternative (octreotide long-acting release at 20 mg\/month or 30\u2009mg\/month, or lanreotide at 90\u2009mg\/month or 120\u2009mg\/month). Outcome measures were mean reduction in foveal thickness (FT) and foveal volume (FV) and mean increase in best-corrected visual acuity at 3, 6 and 12 months of treatment initiation. Linear mixed models were used to calculate the effectiveness over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>52 eyes of 28 RP patients were included; 39% were male. The median age at the start of treatment was 39 years (IQR 30\u201353). Median follow-up was 12 months (range 6\u201312). From baseline to 12 months, the mean FT decreased from 409\u00b1136\u2009\u00b5m to 334\u00b1119\u2009\u00b5m and the mean FV decreased from 0.31\u00b10.10\u2009mm<jats:sup>3<\/jats:sup> to 0.25\u00b10.04\u2009mm<jats:sup>3<\/jats:sup>. Linear mixed model analyses showed a significant decrease in log FT and log FV at 3, 6 and 12 months after the start of treatment compared with baseline measurements (p&lt;0.001, p&lt;0.001, p&lt;0.001). Mean best-corrected visual acuity did not increase significantly (0.46\u00b10.35 logMAR to 0.45\u00b10.38 logMAR after 12 months).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>SA may be an effective alternative treatment to reduce CM in RP patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-001722","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T07:59:19Z","timestamp":1723449559000},"page":"e001722","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Somatostatin analogues as a treatment option for cystoid maculopathy in retinitis pigmentosa"],"prefix":"10.1136","volume":"9","author":[{"given":"Pam A T","family":"Heutinck","sequence":"first","affiliation":[{"name":"Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Ingeborgh","family":"van den Born","sequence":"additional","affiliation":[{"name":"Ophthalmology, Rotterdam Eye Hospital and Rotterdam Ophthalmic Institute, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A M","family":"van Laar","sequence":"additional","affiliation":[{"name":"Immunology and Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P Martin","family":"van Hagen","sequence":"additional","affiliation":[{"name":"Immunology and Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dzenita","family":"Smailhodzic","sequence":"additional","affiliation":[{"name":"Ophthalmology, Rotterdam Eye Hospital and Rotterdam Ophthalmic Institute, Rotterdam, The Netherlands"},{"name":"Ophthalmology, Bartim\u00e9us Diagnostic Center for complex visual disorders, Zeist, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda A","family":"Meester-Smoor","sequence":"additional","affiliation":[{"name":"Ophthalmology and Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C W","family":"Klaver","sequence":"additional","affiliation":[{"name":"Ophthalmology and Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"},{"name":"Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie J M","family":"Verhoeven","sequence":"additional","affiliation":[{"name":"Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"},{"name":"Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-9462","authenticated-orcid":false,"given":"Alberta A H J","family":"Thiadens","sequence":"additional","affiliation":[{"name":"Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"2025090110180644000_9.1.e001722.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.03.005"},{"key":"2025090110180644000_9.1.e001722.2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-311964"},{"key":"2025090110180644000_9.1.e001722.3","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00417-022-05649-y","article-title":"Frequency of cystoid macular edema and vitreomacular interface disorders in genetically solved syndromic and non-syndromic retinitis pigmentosa","volume":"260","author":"Marques","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2025090110180644000_9.1.e001722.4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/ICU.0b013e328349229e","article-title":"Macular cysts in retinal dystrophy","volume":"22","author":"Ganesh","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"2025090110180644000_9.1.e001722.5","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309376"},{"key":"2025090110180644000_9.1.e001722.6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1383"},{"key":"2025090110180644000_9.1.e001722.7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","article-title":"Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review","volume":"63","author":"Bakthavatchalam","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"2025090110180644000_9.1.e001722.8","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.895208","article-title":"Management of cystoid macular edema in retinitis pigmentosa: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025090110180644000_9.1.e001722.9","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1530\/eje.0.143s043","article-title":"Somatostatin and somatostatin receptors in retinal diseases","volume":"143 Suppl 1","author":"van Hagen","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2025090110180644000_9.1.e001722.10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ajo.2007.07.039","article-title":"Octreotide long-acting repeatable for the treatment of chronic macular edema in uveitis","volume":"144","author":"Missotten","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"2025090110180644000_9.1.e001722.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2003.10.003"},{"key":"2025090110180644000_9.1.e001722.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802263380917"},{"key":"2025090110180644000_9.1.e001722.13","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.9.1353"},{"key":"2025090110180644000_9.1.e001722.14","doi-asserted-by":"publisher","DOI":"10.1097\/APO.0000000000000290"},{"key":"2025090110180644000_9.1.e001722.15","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15317"},{"key":"2025090110180644000_9.1.e001722.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-87467-6","article-title":"Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion","volume":"11","author":"Wecker","year":"2021","journal-title":"Sci Rep"},{"key":"2025090110180644000_9.1.e001722.17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin analogs in clinical practice: a review","volume":"21","author":"Gomes-Porras","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025090110180644000_9.1.e001722.18","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3748\/wjg.v21.i6.1945","article-title":"Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: a systematic literature review","volume":"21","author":"Broder","year":"2015","journal-title":"WJG"},{"key":"2025090110180644000_9.1.e001722.19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1517\/14740338.2015.1059817","article-title":"Adverse events associated with somatostatin analogs in acromegaly","volume":"14","author":"Grasso","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"2025090110180644000_9.1.e001722.20","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903379525"},{"key":"2025090110180644000_9.1.e001722.21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03346419","article-title":"Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients","volume":"31","author":"Attanasio","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"2025090110180644000_9.1.e001722.22","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.138560"},{"key":"2025090110180644000_9.1.e001722.23","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/IAE.0000000000002756","article-title":"Optical coherence tomography angiography in patients with retinitis pigmentosa-associated cystoid macular edema","volume":"40","author":"Yeo","year":"2020","journal-title":"Retina (Philadelphia, Pa)"},{"key":"2025090110180644000_9.1.e001722.24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00417-020-04913-3","article-title":"The impact of macular edema on microvascular and metabolic alterations in retinitis pigmentosa","volume":"259","author":"Todorova","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2025090110180644000_9.1.e001722.25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41433-018-0043-1","article-title":"Higher retinal vessel oxygen saturation: investigating its relationship with macular oedema in retinitis pigmentosa patients","volume":"32","author":"Bojinova","year":"2018","journal-title":"Eye (Lond)"},{"key":"2025090110180644000_9.1.e001722.26","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9040347","article-title":"The relevance of oxidative stress in the pathogenesis and therapy of retinal dystrophies","volume":"9","author":"B Dom\u00e8nech","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"2025090110180644000_9.1.e001722.27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41433-022-02230-z","article-title":"Cystoid macular oedema without leakage in fluorescein angiography: a literature review","volume":"37","author":"Naseripour","year":"2023","journal-title":"Eye (Lond)"},{"key":"2025090110180644000_9.1.e001722.28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145029","article-title":"Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa","volume":"6","author":"Wu","year":"2021","journal-title":"JCI Insight"},{"key":"2025090110180644000_9.1.e001722.29","unstructured":"Kengetallen SF . SFK data en feiten 2021: het jaar 2020 in cijfers. 2021."},{"key":"2025090110180644000_9.1.e001722.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41464-z","article-title":"Investigating the associations of macular edema in retinitis pigmentosa","volume":"13","author":"Arias","year":"2023","journal-title":"Sci Rep"},{"key":"2025090110180644000_9.1.e001722.31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/IAE.0b013e3181bced93","article-title":"A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid macular edema","volume":"30","author":"Shah","year":"2010","journal-title":"Retina"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-001722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:18:14Z","timestamp":1756747094000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,12]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/bmjophth-2024-001722"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-001722","relation":{},"ISSN":["2397-3269"],"issn-type":[{"type":"electronic","value":"2397-3269"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}